about
Role of Osteopontin in Liver DiseasesHepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinomaRisk stratification system to predict recurrence of intrahepatic cholangiocarcinoma after hepatic resection.miRNA and lncRNA as biomarkers in cholangiocarcinoma(CCA).Transarterial Chemoembolization: A Favorable Postoperative Management to Improve Prognosis of Hepatitis B Virus-associated Intrahepatic Cholangiocarcinoma after Surgical Resection.Risk factors and survival outcomes of biliary complications after adult-to-adult living donor liver transplantation.Prognostic Impact of Cirrhosis in Patients with Intrahepatic Cholangiocarcinoma following Hepatic Resection.Nomogram predicting pulmonary metastasis of hepatocellular carcinoma after liver transplantation.Risk stratification ofhepatic encephalopathy in liver cirrhosis patients: Novel strategy with novel concerns.Current status of liver transplantation for cholangiocarcinoma.Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resection: Novel concerns.Intrahepatic cholangiocarcinoma arising from HBV infection may be a highly selected population for liver transplantationImpact of viral hepatitis B status on outcomes of intrahepatic cholangiocarcinoma: a meta-analysisThe Role of Nrf2 in Liver Disease: Novel Molecular Mechanisms and Therapeutic ApproachesTumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinomaRictor Deficiency Aggravates Hepatic Ischemia/Reperfusion Injury in Mice by Suppressing Autophagy and Regulating MAPK SignalingNervous system and primary liver cancerCholangiocarcinoma: anatomical location-dependent clinical, prognostic, and genetic disparitiesTransarterial chemoembolization versus percutaneous microwave coagulation therapy for recurrent unresectable intrahepatic cholangiocarcinoma: Development of a prognostic nomogramLatent Risk Intrahepatic Cholangiocarcinoma Susceptible to Adjuvant Treatment After Resection: A Clinical Deep Learning ApproachLiver transplantation for locally advanced intrahepatic cholangiocarcinomaIsolation of cancer-associated fibroblasts and its promotion to the progression of intrahepatic cholangiocarcinomaExpression of VEGFR-3 in intrahepatic cholangiocarcinoma correlates with unfavorable prognosis through lymphangiogenesisReply to: IL-26 and the prognosis of hepatocellular carcinoma after resectionImpact of EBV infection and immune function assay for lymphoproliferative disorder in pediatric patients after liver transplantation: A single-center experienceDoes Donor Allograft Microsteatosis Matter? Comparison of Outcomes in Liver Transplantation With a Propensity-Matched CohortExpression of IL-26 predicts prognosis of patients with hepatocellular carcinoma after surgical resection
P50
Q26738504-490585C5-F273-4D62-8380-CB970DA9E83AQ28076535-C9DC450D-CBC3-4F57-9722-992DEC4E8B6DQ33869560-9562235A-1660-4281-AC55-E20E390928B8Q39443955-6497C6B2-0E9F-408B-81F9-B34D1B1E5945Q45325268-C9EAB609-A859-440C-8BF3-61F427C443BDQ47136537-B61C5487-5C1C-4B2C-930D-DEB645C3C472Q47563178-25FF3492-972C-4F1F-AF92-51184D926625Q48507271-60219C09-584D-4801-A3BB-0F141CD8B9BAQ48561595-15A6B896-8876-46AB-9242-0EB8788AFB99Q50070848-43AEC8BD-AD24-40BE-9CA4-1D170675B841Q52688080-FC179A40-3EC6-4566-B202-E721C3D6E85FQ57125123-4CD17A20-F14A-4387-97BB-27C4461298C1Q59358088-88E5000A-6B98-4097-A03B-FAEE31CA4972Q60916607-1D0C35EA-8E28-45F2-AFA7-8F18B61D48B0Q64113017-E9863A37-4E32-4AF0-9177-31C9FF510669Q88089419-B846C5C5-98E5-47FE-A016-3DF309E5F153Q88372801-1F72E79D-5501-450B-AA89-F2B2F061537CQ89640274-33615BD3-BDC1-43D7-A53C-6161D0612A69Q90088630-5847E3BC-1792-415B-8ABD-16B1A782780DQ90094624-CA8359A5-1A00-49CF-A8FD-87E9DC8601A0Q90485207-428BF0DB-46EE-4386-B786-429A2B635E59Q90657588-7652E3A2-42E5-446F-B661-339413BEFF5FQ91028137-4315881D-7750-43F1-BAB1-30DB8448F703Q92386295-4D389667-8A8F-4AF2-8E18-D58B8E4984BAQ92607276-CC3D7CFE-B317-42C9-B790-7EAE55A726CAQ92693394-19625DE3-E8CF-41FC-AF00-95C285F50335Q92906636-C281D5AB-F1BB-41CD-8612-C27185633CA9
P50
description
researcher ORCID ID = 0000-0003-4646-8998
@en
name
Seogsong Jeong
@ast
Seogsong Jeong
@en
Seogsong Jeong
@es
Seogsong Jeong
@nl
type
label
Seogsong Jeong
@ast
Seogsong Jeong
@en
Seogsong Jeong
@es
Seogsong Jeong
@nl
prefLabel
Seogsong Jeong
@ast
Seogsong Jeong
@en
Seogsong Jeong
@es
Seogsong Jeong
@nl
P1153
57190871370
P31
P496
0000-0003-4646-8998